98 related articles for article (PubMed ID: 31678273)
21. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation.
Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK
Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911
[TBL] [Abstract][Full Text] [Related]
22. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
23. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684
[TBL] [Abstract][Full Text] [Related]
24. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
Guilleret I; Benhattar J
Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
[TBL] [Abstract][Full Text] [Related]
25. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines.
Zhang ZX; Wang Y; Tao ZZ; Chen SM; Xiao BK; Zhou T
Cancer Biother Radiopharm; 2014 Sep; 29(7):289-94. PubMed ID: 25153197
[TBL] [Abstract][Full Text] [Related]
26. ZNF382 controls mouse neuropathic pain via silencer-based epigenetic inhibition of Cxcl13 in DRG neurons.
Ma L; Yu L; Jiang BC; Wang J; Guo X; Huang Y; Ren J; Sun N; Gao DS; Ding H; Lu J; Zhou H; Zou L; Gao Y; Wang L; Sun K; Ming Y; Meng Z; Tao YX; Yan M
J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34762123
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
28. Regulation of AURKC expression by CpG island methylation in human cancer cells.
Fujii S; Srivastava V; Hegde A; Kondo Y; Shen L; Hoshino K; Gonzalez Y; Wang J; Sasai K; Ma X; Katayama H; Estecio MR; Hamilton SR; Wistuba I; Issa JP; Sen S
Tumour Biol; 2015 Sep; 36(10):8147-58. PubMed ID: 25990457
[TBL] [Abstract][Full Text] [Related]
29. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.
Palmisano WA; Crume KP; Grimes MJ; Winters SA; Toyota M; Esteller M; Joste N; Baylin SB; Belinsky SA
Cancer Res; 2003 Aug; 63(15):4620-5. PubMed ID: 12907641
[TBL] [Abstract][Full Text] [Related]
30. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
31. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
[TBL] [Abstract][Full Text] [Related]
32. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation and carcinogenesis of PRDM5 in cervical cancer.
Cheng HY; Chen XW; Cheng L; Liu YD; Lou G
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1821-5. PubMed ID: 20213097
[TBL] [Abstract][Full Text] [Related]
34. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene.
Pang RT; Lee LT; Ng SS; Yung WH; Chow BK
Mol Endocrinol; 2004 Feb; 18(2):471-83. PubMed ID: 14645499
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor WT1 and promoter CpG hypomethylation coactivate HOXA10 expression in ovarian cancer.
Jiang Y; Chu Y; Tang W; Wan Y; Zhang L; Cheng W
Curr Pharm Des; 2014; 20(11):1647-54. PubMed ID: 23888944
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
[TBL] [Abstract][Full Text] [Related]
37. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
Deng G; Song GA; Pong E; Sleisenger M; Kim YS
Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
[TBL] [Abstract][Full Text] [Related]
39. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H
Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666
[TBL] [Abstract][Full Text] [Related]
40. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]